Director, R&D Strategic Sourcing and Procurement

. Madrigal's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key... underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the...

Lugar: Conshohocken, PA | 24/12/2025 19:12:14 PM | Salario: S/. $202000 - 246000 per year | Empresa: Madrigal

Director, Project Management

. Madrigal's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key... underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the...

Lugar: Conshohocken, PA | 25/12/2025 00:12:00 AM | Salario: S/. $200000 - 244000 per year | Empresa: Madrigal

Medical Science Liaison-New York

. Madrigal's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key... underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the...

Lugar: New York City, NY | 06/01/2026 18:01:09 PM | Salario: S/. $195300 - 238700 per year | Empresa: Madrigal

Associate Director, Generative AI Engineer

. Madrigal's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key... underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the...

Lugar: Conshohocken, PA | 26/11/2025 02:11:57 AM | Salario: S/. $191000 - 234000 per year | Empresa: Madrigal

Associate Director, Specialty and IDN Operations

. Madrigal's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key... underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the...

Lugar: Massachusetts | 18/12/2025 03:12:04 AM | Salario: S/. $182000 - 222000 per year | Empresa: Madrigal

Associate Director, Global Health Economics and Outcomes Research

. Madrigal's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key... underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the...

Lugar: Massachusetts | 22/11/2025 03:11:40 AM | Salario: S/. $179000 - 219000 per year | Empresa: Madrigal